Pro Share Advisors LLC Surface Oncology, Inc. Transaction History

Pro Share Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$1.42 - $3.15 $16,186 - $35,906	-11,399 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$2.65 - $5.08 $7,465 - $14,310	-2,817 Reduced 19.82%	11,399 $33,000
Q4 2021 Feb 08, 2022	BUY	$4.73 - $7.9 $212 - $355	45 Added 0.32%	14,216 $68,000
Q3 2021 Nov 12, 2021	SELL	$5.16 - $7.98 $11,687 - $18,074	-2,265 Reduced 13.78%	14,171 $107,000
Q2 2021 Aug 13, 2021	BUY	$6.45 - $9.09 $106,012 - $149,403	16,436 New	16,436 $123,000
Q2 2019 Aug 13, 2019	SELL	$2.75 - $4.89 $29,238 - $51,990	-10,632 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$4.11 - $5.88 $238 - $341	58 Added 0.55%	10,632 $51,000
Q4 2018 Feb 14, 2019	BUY	$3.65 - $10.69 $38,595 - $113,036	10,574 New	10,574 $45,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.